AOD-9604 is not a drug, supplement, or food product, and is not for human consumption, veterinary use, or medical applications
However it is yet to be approved for human consumption and remains a research compound
Although we expected the largest microbiome differences to occur in the lean control group relative to the obese control group, we found that the diet-switched groups exhibited a greater number of differences from the control groups than the control groups did from one another
Some conditions, like pernicious anemia, make it hard for your body to absorb B12
Extended Protocol (24 Weeks): The longest clinical trial evaluated 24-week daily administration with doses of 0.25 mg, 0.5 mg, and 1 mg